The global women’s health diagnostics market is projected to grow significantly, reaching a value of USD 31.46 billion by 2030, according to a recent report from ResearchAndMarkets.com. The market is anticipated to expand at a compound annual growth rate (CAGR) of 7.29% from 2025 to 2030.
Several factors are contributing to this growth, including the rising adoption of point-of-care diagnostics and an increase in the incidence of chronic and lifestyle-related diseases. Furthermore, awareness programs aimed at educating the public about women’s health are expected to further fuel market expansion during the forecast period.
Government funding and rising investments in healthcare are playing a pivotal role in boosting the development of women’s health diagnostics. The market is divided by end use, with hospitals and diagnostic centers holding a dominant share due to their higher volume of patient visits and more reliable diagnostic capabilities. However, the home diagnostics segment is also experiencing growth as patients seek more accessible and convenient testing options.
In terms of regional growth, the Asia-Pacific market is expected to see significant expansion. This growth is largely driven by increased healthcare investments, a growing emphasis by international device manufacturers on strengthening their distribution networks within the region, and a shift from infectious diseases to chronic conditions. This shift is further contributing to the region’s burgeoning demand for women’s health diagnostic solutions.
With these developments, the women’s health diagnostics market is poised for substantial growth, supported by both strategic investments and a shifting healthcare landscape.
Related topics
